4th Quarter - Report
BRAVO GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Firm
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Biopharmaceutical issues including colon, social and economic, value of the biopharmaceutical sector, patient access and safety issues, life science innovation, and job impact.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRIS BRAVACOS | — |
| TED PIPER | — |
| JENNIFER LAURA RILEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.